Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Recent GLP-1 Weight Loss Drug Market Developments: Novo Nordisk, Eli Lilly, Amgen, and FDA Lead 20252026 April 2026: Eli Lilly submitted the orforglipron New Drug Application to the FDA for obesity treatment, reporting 14.7% body weight reduction in the ATTAIN-WEIGHT1 Phase 3 trial at the 45mg dose the first oral small molecule GLP-1 receptor agonist NDA submission for dedicated obesity pharmacological treatment in the United States
Suitable for skin types All skin types For age range 18 and above Made in Korea Shelf life 11/2028 12 M PAO How to use After cleansing, pat a small amount of eye cream around the contour of the eye using your ring finger
For optimal antioxidant support, choose optimal delivery
Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
US$ 28.07
US$ 25.58
US$ 23.46
US$ 21.22
